SAVE THE DATE:
2018 CIMT Annual Meeting
May 15-17, 2018
Rheingoldhalle Congress Center
15th CIMT Annual Meeting
May 10 – 11, 2017
The 15th meeting of the Association for Cancer Immunotherapy is a 1.5-day symposium that will celebrate the accomplishments of cancer immunotherapy research by presenting an overview of past and present studies and by discussing clinical and translational developments.
The symposium is free of charge for CIMT members and includes participation in the CIMT Lifetime Achievement Award Ceremony and Reception.
Non-members are welcome. For more information, please go to meeting.cimt.eu.
CIMT actively participates in international cancer and immunology meetings by sponsoring sessions and workshops dedicated to the topic of cancer immunotherapy.
Endeavour is a CIMT activity focusing on the translation and commercialization of cancer immunotherapies and diagnostics. Eandeavour workshops have allowed scientists from the cancer immunotherapy community to present their innovation to business experts and venture capital representatives with a focus on funding initiatives, viable business models and product development. Participants have shared and discussed the challenges that European and American biotech companies face in early, middle and late stage development.
CIMT Endeavour is supported by a grant of the Federal Ministry of Education and Research (BMBF).
To learn more, please go to http://endeavour.cimt.eu/.
"Translating Science into Survival"
September 6-9, 2017, Mainz/Frankfurt, Germany
The Cancer Research Institute (CRI), the Association for Cancer Immunotherapy (CIMT), the European Academy of Tumor Immunology (EATI), and the American Association for Cancer Research (AACR) are proud to once again join forces to sponsor the Third Annual CRI-CIMT-EATI-AACR INTERNATIONAL CANCER IMMUNOTHERAPY CONFERENCE, which will take place in Mainz, Germany from September 6-9, 2017.
The International Cancer Immunotherapy Conference covers all areas of inquiry in cancer immunology and immunotherapy. Launched in 2015, the meeting is jointly sponsored by the Cancer Research Institute (CRI), the Association for Cancer Immunotherapy (CIMT), the European Academy of Tumor Immunology (EATI), and the American Association for Cancer Research (AACR). The meeting is held every year and alternates between the United States and Europe. Through this collaboration, the organizations aim to more effectively and efficiently disseminate the latest cutting-edge information and research in cancer immunology and immunotherapy, and to provide an opportunity for teaching, learning, and networking among all stakeholders in the field.
Prague, Czech Republic
April 24-27, 2017
The Fifth International Conference on Cancer Immunotherapy & Immunomonitoring (CITIM) serves biomedical scientists and researchers, primary care physicians, medical residents and fellows, RN, medical technologists, postdoctoral fellows, medical and graduate students. http://www.canceritim.org/
February 1-3, 2017
The Roosevelt Hotel, New York, New York
The 3rd annual Immuno-Oncology 360° provides a unique 360-degree approach addressing the most-up-to-date information regarding business aspects, clinical advancements and scientific data that will help accelerate clinical trials and FDA approval, ultimately transforming the way cancer is treated.
With the support of the Cancer Research Institute (CRI), The Society for Immunotherapy of Cancer (SITC) and The Association for Cancer Immunotherapy (CIMT), this conference attracts national and international experts and thought leaders from large pharma, biotech, investment community, academia and research organizations as part of the speaking faculty and attendees.
A 20% registration discount applies to CIMT members.
FOCIS 2017 - the annual meeting of the Federation of Clinical Immunology Societies (FOCIS)
June 14-17, 2017
Hilton Chicago Hotel